Silo Pharma, Inc. (SILO) Financials

$0.58

$0 (0.59%)
Last update: 11:43 AM EST
Day's range
$0.56
Day's range
$0.59
$4M$4M$2M$2M$0$0-$2M-$2M-$4M-$4M-$6M-$6MEarning2018201820192019202020202021202120222022202320232024202415000%15000%10000%10000%5000%5000%0%0%-5000%-5000%-10000%-10000%Profit Margin
Profit Margin
Revenue
Earnings

SILO Income statement / Annual

Last year (2024), Silo Pharma, Inc.'s total revenue was $72.10 K, a decrease of 0.00% from the previous year. In 2024, Silo Pharma, Inc.'s net income was -$4.39 M. See Silo Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $72.10 K $72.10 K $72.10 K $71.26 K $40.92 K $40.57 K $0.00 $847.41 K -$669.48 K -$145.19 K
Cost of Revenue $5.84 K $5.84 K $5.84 K $5.00 K $176.13 K $27.39 K $17.55 K $0.00 $0.00 $0.00
Gross Profit $66.26 K $66.26 K $66.26 K $66.26 K -$135.20 K $13.18 K -$17.55 K $847.41 K -$669.48 K -$145.19 K
Gross Profit Ratio 0.92 0.92 0.92 0.93 -3.3 0.32 0 1 1 1
Research and Development Expenses $2.37 M $845.09 K $1.29 M $693.91 K $88.80 K $63.47 K $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $2.40 M $3.08 M $2.43 M $2.27 M $2.18 M $864.18 K $459.83 K $313.37 K $300.99 K $167.70 K
Selling & Marketing Expenses $0.00 $0.00 -$1.27 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $2.40 M $3.08 M $2.43 M $2.27 M $2.18 M $864.18 K $459.83 K $313.37 K $300.99 K $167.70 K
Other Expenses $0.00 $0.00 $2.17 M $1.95 M $3.00 K $765.72 K $314.61 K $177.50 K $142.50 K $96.61 K
Operating Expenses $4.77 M $3.92 M $3.71 M $2.96 M $2.27 M $927.65 K $459.83 K $490.87 K $443.49 K $264.31 K
Cost And Expenses $4.77 M $3.93 M $3.72 M $2.96 M $2.45 M $955.03 K $459.83 K $427.96 K $443.49 K $264.31 K
Interest Income $333.17 K $398.53 K $72.64 K $1.21 K $11.54 K $12.20 K $4.22 K $20.48 K $49.84 K $40.34 K
Interest Expense $5.08 K $4.87 K $2.20 K $3.04 K $269.27 K $62.93 K $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $6.19 K $229.38 K $72.64 K -$147.29 K $179.92 K $28.14 K $17.55 K -$701.10 K $719.32 K $192.33 K
EBITDA -$4.38 M -$3.63 M -$3.91 M $4.19 M -$2.39 M -$930.40 K -$951.91 K $0.00 $0.00 -$217.17 K
EBITDA Ratio -60.77 -50.29 -54.16 58.73 -58.48 -22.93 0 0 0 1.5
Operating Income Ratio -65.26 -53.47 -50.59 -38.51 -62.87 -22.93 0 -0.56 0.59 1.5
Total Other Income/Expenses Net $312.81 K $224.51 K -$279.73 K $6.93 M -$464.55 K -$82.89 K -$375.22 K $826.92 K -$719.32 K -$192.33 K
Income Before Tax -$4.39 M -$3.63 M -$3.91 M $4.18 M -$3.04 M -$1.01 M -$969.46 K $356.54 K -$1.11 M -$409.50 K
Income Before Tax Ratio -60.93 -50.36 -54.19 58.68 -74.23 -24.98 0 0.42 1.66 2.82
Income Tax Expense $0.00 $0.00 $1.16 K $24.88 K $92.35 K $34.79 K -$513.85 K -$62.91 K $696.50 K $0.00
Net Income -$4.39 M -$3.70 M -$3.91 M $3.90 M -$3.13 M -$1.05 M -$969.46 K $356.54 K -$1.11 M -$409.50 K
Net Income Ratio -60.93 -51.33 -54.21 54.78 -76.48 -25.83 0 0.42 1.66 2.82
EPS -1.19 -1.2 -1.71 2.06 -2.37 -1.24 -0.99 0.5 -1.11 -0.4
EPS Diluted -1.19 -1.2 -1.71 2.03 -2.37 -1.24 -0.99 0.5 -1.11 -0.4
Weighted Average Shares Out $3.68 M $3.08 M $2.28 M $1.90 M $1.32 M $842.30 K $982.03 K $1.00 M $1.00 M $1.01 M
Weighted Average Shares Out Diluted $3.68 M $3.08 M $2.28 M $1.92 M $1.32 M $842.30 K $982.03 K $1.04 M $1.00 M $1.01 M
Link